Hospital
The Brookdale Hospital Medical Center
The Brookdale Hospital Medical Center was paid $15.22M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.
33Billing provider infoTHE BROOKDALE HOSPITAL MEDICAL CENTER
BROOKLYN, NY 11212
BROOKLYN, NY 11212
33aNPI1356307656assigned 04/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.22M
24GClaims310,083
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#70 of 231
Median peer was paid$561K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,813 | $272K | |
| 2019 | 24,204 | $1.01M | |
| 2020 | 53,089 | $2.30M | |
| 2021 | 68,904 | $2.72M | |
| 2022 | 57,427 | $3.49M | |
| 2023 | 70,662 | $4.04M | |
| 2024incomplete | 29,984 | $1.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 15,559 | 12,691 | $2.29M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 12,908 | 11,196 | $1.68M |
| 36415 | Collection of venous blood by venipuncture | 9.8% | 62,727 | 23,730 | $1.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 9,116 | 8,621 | $1.32M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.6% | 6,286 | 6,042 | $1.01M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.8% | 10,555 | 8,088 | $733K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.7% | 4,551 | 4,054 | $718K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.4% | 2,763 | 2,551 | $676K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.7% | 3,894 | 2,823 | $413K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 1,519 | 1,494 | $407K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 2,892 | 2,500 | $352K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.2% | 678 | 666 | $333K |
211 more codes
| 80053 | Comprehensive metabolic panel | 2.1% | 15,292 | $321K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 1,893 | $261K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 1,442 | $251K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 1,014 | $247K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.3% | 405 | $197K |
| 81025 | 1.3% | 7,284 | $194K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.1% | 1,518 | $167K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.0% | 2,954 | $158K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.0% | 1,571 | $157K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 3,931 | $155K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 764 | $129K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,104 | $121K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 733 | $114K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,249 | $100K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,678 | $67K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 711 | $55K |
| 80061 | Lipid panel | <1% | 4,793 | $55K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,628 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,214 | $42K |
| 82962 | <1% | 4,160 | $42K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 258 | $38K |
| 83880 | <1% | 1,373 | $37K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 303 | $36K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 149 | $33K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 114 | $29K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 883 | $28K |
| 86480 | <1% | 466 | $28K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 942 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,333 | $26K |
| 88142 | <1% | 574 | $26K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 46 | $24K |
| 90686 | <1% | 892 | $24K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 242 | $23K |
| 86900 | <1% | 738 | $22K | |
| 86901 | <1% | 633 | $21K | |
| 93970 | <1% | 64 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 93 | $20K |
| 11721 | <1% | 291 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 189 | $18K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,070 | $18K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,194 | $18K |
| 90715 | <1% | 514 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,934 | $15K |
| 76641 | <1% | 399 | $15K | |
| 97010 | <1% | 1,454 | $14K | |
| 86360 | <1% | 396 | $13K | |
| 86850 | <1% | 492 | $12K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 148 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,945 | $10K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 52 | $10K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 474 | $10K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 197 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 583 | $9K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 86 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,764 | $8K |
| D0120 | Dental checkup, returning patient | <1% | 289 | $8K |
| 81001 | <1% | 7,705 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,440 | $7K |
| 97162 | <1% | 87 | $7K | |
| 86803 | <1% | 2,028 | $6K | |
| 87536 | <1% | 271 | $6K | |
| 1033F | <1% | 496 | $6K | |
| 76770 | <1% | 15 | $6K | |
| 84439 | <1% | 2,034 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,293 | $6K |
| 96367 | <1% | 286 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 272 | $5K |
| 96127 | <1% | 6,063 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,168 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,624 | $5K |
| 99201 | <1% | 79 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,659 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,384 | $5K |
| 82607 | <1% | 1,118 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 215 | $4K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 403 | $4K |
| 82947 | <1% | 899 | $4K | |
| 73630 | <1% | 673 | $4K | |
| 92133 | <1% | 58 | $4K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 14 | $3K |
| 99441 | <1% | 120 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 857 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 28 | $3K |
| 11055 | <1% | 19 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $3K |
| 1036F | <1% | 343 | $3K | |
| J3490 | Unclassified drugs | <1% | 1,334 | $3K |
| 85730 | <1% | 1,538 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,389 | $3K |
| 90651 | <1% | 12 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $3K |
| 82803 | <1% | 95 | $3K | |
| 86780 | <1% | 1,001 | $3K | |
| 90750 | <1% | 14 | $3K | |
| 85610 | <1% | 1,579 | $2K | |
| 87070 | <1% | 146 | $2K | |
| 82570 | <1% | 403 | $2K | |
| 82043 | <1% | 1,194 | $2K | |
| 86706 | <1% | 807 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 68 | $2K |
| 99442 | <1% | 63 | $2K | |
| 82728 | <1% | 552 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 48 | $2K |
| 71250 | <1% | 12 | $2K | |
| 87340 | <1% | 698 | $2K | |
| 86769 | <1% | 166 | $1K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 57 | $1K |
| 73610 | <1% | 121 | $1K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 258 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 48 | $1K |
| 73562 | <1% | 240 | $1K | |
| 80305 | <1% | 748 | $1K | |
| 84484 | <1% | 3,047 | $1K | |
| 99443 | <1% | 20 | $1K | |
| 84702 | <1% | 960 | $988.17 | |
| 80074 | <1% | 80 | $873.05 | |
| 84480 | <1% | 317 | $853.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,335 | $795.40 |
| 82746 | <1% | 181 | $754.51 | |
| 88304 | <1% | 13 | $748.72 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 629 | $721.08 |
| D1110 | Prophylaxis - adult | <1% | 15 | $716.15 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 511 | $673.68 |
| 73130 | <1% | 93 | $648.08 | |
| 72100 | <1% | 56 | $600.60 | |
| 82652 | <1% | 42 | $596.61 | |
| 90662 | <1% | 14 | $587.86 | |
| 86704 | <1% | 261 | $571.02 | |
| 86762 | <1% | 157 | $556.61 | |
| 83690 | <1% | 1,846 | $548.51 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 923 | $502.94 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 450 | $484.75 |
| 81003 | <1% | 1,282 | $463.82 | |
| 73560 | <1% | 41 | $462.60 | |
| 85732 | <1% | 138 | $459.62 | |
| 83735 | <1% | 1,093 | $438.16 | |
| 86765 | <1% | 128 | $431.69 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 269 | $415.70 |
| 83970 | <1% | 13 | $337.21 | |
| 83550 | <1% | 368 | $332.81 | |
| 84153 | <1% | 104 | $327.79 | |
| 86592 | <1% | 271 | $314.23 | |
| 1159F | <1% | 326 | $299.48 | |
| 1126F | <1% | 232 | $284.07 | |
| J2704 | Injection, propofol, 10 mg | <1% | 351 | $272.81 |
| 87088 | <1% | 122 | $251.18 | |
| 85379 | <1% | 564 | $240.21 | |
| 86593 | <1% | 272 | $231.98 | |
| 83605 | <1% | 439 | $229.77 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 622 | $224.90 |
| 86735 | <1% | 71 | $221.71 | |
| Q3014 | Telehealth originating site facility fee | <1% | 36 | $210.36 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 28 | $206.85 |
| 85651 | <1% | 331 | $191.94 | |
| 73030 | <1% | 65 | $186.53 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 968 | $185.92 |
| S0028 | Injection, famotidine, 20 mg | <1% | 67 | $177.30 |
| 87040 | <1% | 250 | $175.35 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 673 | $170.68 |
| 86141 | <1% | 115 | $138.52 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $116.00 |
| G0008 | Administration of influenza virus vaccine | <1% | 43 | $111.87 |
| 82948 | <1% | 1,636 | $105.73 | |
| 84100 | <1% | 146 | $97.82 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 61 | $89.60 |
| 82550 | <1% | 280 | $81.06 | |
| 82150 | <1% | 195 | $80.48 | |
| 73590 | <1% | 12 | $64.69 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 79 | $59.25 |
| D0330 | Panoramic radiographic image | <1% | 14 | $57.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 285 | $52.99 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 12 | $30.73 |
| 86705 | <1% | 15 | $30.30 | |
| 80320 | <1% | 144 | $30.10 | |
| 84156 | <1% | 27 | $28.92 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 131 | $28.61 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 17 | $18.00 |
| 86140 | <1% | 41 | $9.18 | |
| 85007 | <1% | 60 | $8.58 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 12 | $6.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 100 | $5.76 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 53 | $4.95 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 29 | $0.91 |
| 3044F | <1% | 358 | $0.02 | |
| 3062F | <1% | 130 | $0.01 | |
| 82248 | 0% | 15 | $0.00 | |
| 3725F | 0% | 113 | $0.00 | |
| 3078F | 0% | 147 | $0.00 | |
| 99080 | 0% | 576 | $0.00 | |
| 1160F | 0% | 252 | $0.00 | |
| 3077F | 0% | 36 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 17 | $0.00 |
| 3051F | 0% | 17 | $0.00 | |
| 73110 | 0% | 13 | $0.00 | |
| 3046F | 0% | 18 | $0.00 | |
| 3288F | 0% | 29 | $0.00 | |
| 3050F | 0% | 18 | $0.00 | |
| 3075F | 0% | 41 | $0.00 | |
| 3048F | 0% | 133 | $0.00 | |
| 3061F | 0% | 162 | $0.00 | |
| 3008F | 0% | 208 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 16 | $0.00 |
| 3074F | 0% | 149 | $0.00 | |
| 3079F | 0% | 80 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 12 | $0.00 |
| 3049F | 0% | 50 | $0.00 | |
| 1170F | 0% | 17 | $0.00 | |
| 85652 | 0% | 14 | $0.00 | |
| 4010F | 0% | 95 | $0.00 | |
| 1125F | 0% | 18 | $0.00 | |
| 3052F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFIGUEROA, MICHELLE (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| The Brookdale Hospital Medical Center | Brooklyn, NY | $44.03M |
| Brookdale Family Care Center, INC. | Brooklyn, NY | $8.17M |
| Urban Strategies Brookdale Family Care Center INC | Brooklyn, NY | $2.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.